MBT Sepsityper® Solution
Bruker's MBT Sepsityper® solution is designed to integrate seamlessly with the MALDI Biotyper®. This powerful combination enables the identification of pathogens directly from positive blood cultures in just 15-20 minutes, offering a cost-effective and efficient workflow that can significantly enhance patient care.
Receive your quote directly from the manufacturer.
Sepsis is a life-threatening condition impacting over 30 million individuals globally each year. Prompt identification of the causative pathogen is essential for enhancing patient outcomes, reducing morbidity and mortality, and lowering healthcare costs. The MBT Sepsityper® Solution, in conjunction with the MALDI Biotyper®, can significantly expedite the diagnostic process, reducing turnaround times by up to 48 hours compared to traditional laboratory methods.
Key Features & Benefits
- Direct sample processing from positive blood cultures (PBC)
- Less than 10 minutes of hands-on time
- Results available within 15-20 minutes post-PBC alert with the Rapid Sepsityper® Workflow
- Facilitates early adjustment of antibiotic therapy
- Contributes to overall hospital cost reduction
- Improves patient outcomes and combats antimicrobial resistance (AMR)
